SUMITOMO HEAVY INDUSTRIES, LTD.

Sound Wave Innovation and Sumitomo Heavy Industries Partner to Advance LIPUS-Brain Device for Alzheimer's Treatment

- Sound Wave Innovation and Sumitomo Heavy Industries announced a strategic alliance to manufacture and distribute the LIPUS-Brain transcranial low-intensity pulsed ultrasound therapeutic device for early-stage Alzheimer's disease patients. - The LIPUS-Brain device demonstrated high safety and efficacy in a 2022 exploratory clinical trial and became the first "Breakthrough Medical Device" designated by Japan's PMDA in September 2022. - The companies anticipate completing pivotal clinical trials by end of 2026 with medical device approval targeted for 2027, followed by nationwide expansion to medical institutions. - This minimally invasive ultrasound technology represents a potential breakthrough in addressing the growing global challenge of Alzheimer's disease and dementia treatment.